New drug development for pediatric oncology.
Weitman
S
S
Department of Pediatric Oncology, Hematology and Immunology, University of Texas Health Science Center, San Antonio, USA.
Carlson
L
L
Pratt
C B
CB
D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents